OncoSec Medical Inc (ONCSQ)

[guti]

thank you daskapital, I am happy for you to be a part of this immunotherapy technology that Oncosec is working on. I think Dr. Pierce knew exactly what type of result to expect, after he had been practically the one who began successfully working with anti PD-1. You are correct about Daniel O'Connor, he made a deal with Merck for Advaxis, but their problems began after a phase3 study was discontinued due to bad results. Advaxis at the time was working in many different types of studies, which probably took a toll on things. Oncosec has only one thing to focus on, electroporation of IL-12, and I believe IL-12 has been studied for many years for a very good reason. Maybe this is its time to shine.